Insider Transactions in Q2 2024 at Senseonics Holdings, Inc. (SENS)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2024
|
Timothy T Goodnow President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
275,206
-2.31%
|
$0
$0.39 P/Share
|
|
Jun 15
2024
|
Frederick T. Sullivan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
79,242
-3.03%
|
$0
$0.39 P/Share
|
|
Jun 15
2024
|
Kenneth L Horton GC & Corp. Development Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
80,785
-2.72%
|
$0
$0.39 P/Share
|
|
Jun 15
2024
|
Mukul Jain Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
132,448
-2.57%
|
$0
$0.39 P/Share
|
|
Jun 15
2024
|
Francine Kaufman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
64,722
-2.66%
|
$0
$0.39 P/Share
|
|
May 23
2024
|
Timothy T Goodnow President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,553,551
+27.67%
|
-
|
|
May 23
2024
|
Frederick T. Sullivan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,336,005
+33.82%
|
-
|
|
May 23
2024
|
Mukul Jain Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,204,408
+29.98%
|
-
|
|
May 23
2024
|
Kenneth L Horton GC & Corp. Development Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
1,135,604
+27.63%
|
-
|
|
May 23
2024
|
Francine Kaufman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,024,270
+29.66%
|
-
|
|
May 22
2024
|
Douglas A Roeder |
BUY
Grant, award, or other acquisition
|
Direct |
236,344
+18.45%
|
-
|
|
May 22
2024
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
236,344
+18.02%
|
-
|
|
May 22
2024
|
Stephen P De Falco |
BUY
Grant, award, or other acquisition
|
Direct |
236,344
+11.0%
|
-
|
|
May 22
2024
|
Sharon Larkin |
BUY
Grant, award, or other acquisition
|
Direct |
236,344
+30.89%
|
-
|
|
May 22
2024
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
236,344
+21.07%
|
-
|
|
May 22
2024
|
Anthony R. Raab |
BUY
Grant, award, or other acquisition
|
Direct |
236,344
+25.22%
|
-
|
|
May 22
2024
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct |
236,344
+19.0%
|
-
|
|
May 15
2024
|
Kenneth L Horton GC & Corp. Development Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
108,100
-5.55%
|
$0
$0.5 P/Share
|
|
May 15
2024
|
Mukul Jain Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
151,796
-4.9%
|
$0
$0.5 P/Share
|
|
May 15
2024
|
Francine Kaufman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
53,923
-3.7%
|
$0
$0.5 P/Share
|
|
May 15
2024
|
Timothy T Goodnow President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
359,114
-4.66%
|
$0
$0.5 P/Share
|
|
May 15
2024
|
Frederick T. Sullivan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
102,386
-7.41%
|
$0
$0.5 P/Share
|
|
Apr 02
2024
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct |
25,245
+3.17%
|
$0
$0.51 P/Share
|
|
Apr 02
2024
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct |
27,696
+3.2%
|
$0
$0.51 P/Share
|
|
Apr 02
2024
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct |
15,931
+2.4%
|
$0
$0.51 P/Share
|